Kala Pharmaceuticals to Present at Upcoming Investor Conferences in September
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that members of its management team will participate virtually in the following upcoming conferences: H.C. Wainwright 22nd Annual Global Investment Conference Date: Monday, September 14, 2020 Presentation Time: 1:00 p.m. ET 2020 Cantor Global Healthcare Conference Date